Review Articles

Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Giga-Hematology University of Liège, Belgium
Hopital Saint-Antoine, AP-HP, Paris, France;Université Pierre & Marie Curie, Paris, France;INSERM UMRs U938, Paris, France
Aix Marseille Univ, CNRS, INSERM, CRCM, Institut Paoli-Calmettes, Marseille, France
AP-HP, Hematology Transplantation, Hospital Saint-Louis, Paris, France
Hopital Saint-Antoine, AP-HP, Paris, France;INSERM UMRs U938, Paris, France
Department of Hematology, Hospital Clinic, Barcelona, Spain
Department of Hematology, Ospedale San Raffaele, Università degli Studi, Milano, Italy
Maria Sklodowska-Curie Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland
Hopital Saint-Antoine, AP-HP, Paris, France
Long term Transplant Clinic, Vanderbilt University Medical Center, Nashville, TN, USA
Klinikum Augsburg, Department of Hematology and Oncology, University of Munich, Augsburg, Germany
Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel;EBMT Paris Office, Hospital Saint Antoine, Paris, France
Vol. 102 No. 2 (2017): February, 2017